TAS-108

TAS-108 Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name TAS-108
Generic TAS-108
Type
Formula C39H55NO10
Weight Average: 697.866
Monoisotopic: 697.382596975
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
TAS-108
TAS-108

Uses

Investigated for use/treatment in breast cancer.

How TAS-108 works

TAS-108 binds to and inhibits estrogenic receptor alpha (ERa), mainly expressed in the mammary gland and uterus and upregulated in estrogen-dependent tumors. Blockage of ERa by TAS-108 prevents the binding and effects of estrogen and may lead to an inhibition of estrogen-dependent cancer cell proliferation. TAS-108 also is a partial agonist of the estrogenic receptor beta (ERb), expressed in many tissues including the central nervous system, urogenital tract, bone and cardiovascular system, thereby exerting a positive effect on these tissues. In addition, TAS-108 activates the co-repressor Silencing Mediator for Retinoid and Thyroid hormone receptor (SMRT), a protein that inhibits the activities of the estrogen receptors, which may contribute to the antitumor activity of TAS-108.

Innovators Monograph

You find simplified version here TAS-108

*** Taking medicines without doctor's advice can cause long-term problems.
Share